Drug ID: | NPD4628 |
Drug Name: | Lifibrol |
Molecular Formula: | C21H26O4 |
Canonical SMILES: | OC(COc1ccc(cc1)C(=O)O)CCc1ccc(cc1)C(C)(C)C |
Standard InCHI: | InChI=1S/C21H26O4/c1-21(2,3)17-9-4-15(5-10-17)6-11-18(22)14-25-19-12-7-16(8-13-19)20(23)24/h4-5,7-10,12-13,18,22H,6,11,14H2,1-3H3,(H,23,24) |
Standard InCHIKey: | LNXBEIZREVRNTF-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB000857 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 342.18 |
ALogP | 0.4376 |
MLogP | 3.33 |
XLogP | 7.18 |
HDA | 3 |
HBD | 2 |
Rotatable Bonds | 13 |
TPSA | 66.76 |
RO5 Violation | 1 |